This subset of tumours was more likely to show MSI, with MLH1 hypermethylation, TP53 wild-type, and mutations in CHD7 or CHD8. The shared CIMP+ molecular profile of Fn CRCs supported its pathogenic role in this subset of tumours. The gene discussed is TP53; the disease is neoplasm.